Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-20-065001

Options or other derivatives

  • VP, Finance acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Selby Brian L. VP, Finance 2020-12-21 Grant or award · Stock Option (right to buy) +55,000 55,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…